Sandoz Korea seeking to enhance its corporate entity

Sandoz Korea says it will promote its own marketing of 12 generic products, including paroxetine, until next year, while placing more emphasis on better recognition of the corporate entity from the domestic medical field.

The in-house survey shows that Sandoz Korea has had little awareness, necessitating our strenuous efforts to promote our corporate image as one of the generic makers to pro...